|Bid||0.00 x 800|
|Ask||0.00 x 1100|
|Day's Range||291.60 - 297.62|
|52 Week Range||216.47 - 299.00|
|Beta (3Y Monthly)||1.07|
|PE Ratio (TTM)||39.91|
|Earnings Date||Jun 5, 2019 - Jun 10, 2019|
|Forward Dividend & Yield||0.06 (0.02%)|
|1y Target Est||312.50|
Moody's Investors Service has assigned a Baa2 long-term issuer rating to Alcon Inc. ("Alcon" or "the company"). This is the first time that Moody's assigned ratings to Alcon, a global manufacturer of eye care medical equipment and products which is being spun off from Novartis AG (Novartis, A1 stable).
Cooper Companies (COO) maintains its leading position in the markets of specialty lenses, supported by highly exclusive products like Biofinity and Clariti.
PLEASANTON, Calif., March 18, 2019 /PRNewswire/ -- Multiple new CooperVision initiatives in major world markets are providing a glimpse at the company's commitment to addressing the global myopia epidemic. Eye care professional (ECP)-focused standards development and educational programs are taking root in Australia and New Zealand. The company is seeing record enrollment among ECPs for this month's "Myopia Management – The Time to Act is Now" CPD-accredited continuing education events in Sydney, Melbourne & Brisbane.
PLEASANTON, Calif., March 14, 2019 /PRNewswire/ -- Affirming its role as a global leader in myopia management, CooperVision is voicing strong support for the publication of eight highly-anticipated white papers by the International Myopia Institute (IMI). Released within the past several days, the reports cover a range of topics deemed essential to advancing clinical knowledge and practice relating to stemming the expanding impact of myopia. The IMI papers are available in a special edition of Investigative Ophthalmology & Visual Science.
Cooper Companies (COO) maintains its leading position in the markets of specialty lenses. Further, the company exits first-quarter fiscal 2019 on a strong note.
Cooper Companies Inc NYSE:COOView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for COO with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold COO had net inflows of $3.61 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Today we're going to take a look at the well-established The Cooper Companies, Inc. (NYSE:COO). The company's stock received a lot of attention from a substantial price increase on theRead More...
Coupa Software (COUP) benefits from expanding customer base. Further, rising adoption of the company's platform is driving subscription services revenues and gross margin.
Medical supplier Cooper Companies Inc (NYSE: COO ) outperformed first-quarter estimates on an operational basis, and its key account strategy should support share gains, according to Raymond James. The ...
PLEASANTON, Calif., March 05, 2019 -- The Cooper Companies, Inc. (NYSE: COO) today announced financial results for the fiscal first quarter ended January 31, 2019. Revenue.
NEW YORK, NY / ACCESSWIRE / March 5, 2019 / Cooper Companies, Inc. (NYSE: COO ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on March 5, 2019 at 5:00 PM Eastern ...
DENTSPLY SIRONA's (XRAY) overall growth strategy depends on product innovation and R&D focus, which is likely to drive the top line in Q4.
PLEASANTON, Calif., Feb. 12, 2019 -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Barclays Global Healthcare Conference in Miami, FL, on March 12, 2019. Brian.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Investors pursuing a solid, dependable stock investmentRead More...
MEDFORD, Mass. , Feb. 4, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTC: IVOB), developers of the INVOcell intravaginal culture (IVC) system, today announced the appointment of Michael J. Campbell as ...